Detalles de la búsqueda
1.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34597472
2.
A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS® Score and Ethnicity in a Diverse, Multiethnic Population.
J Urol
; 206(3): 586-594, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33881932
3.
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int
; 128(2): 196-205, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33556233
4.
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Cancer
; 126(6): 1208-1216, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31829450
5.
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
J Urol
; 204(1): 63-70, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31971495
6.
Editorial Comment.
J Urol
; 208(4): 828-829, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830563
7.
The Impact of Holistic Review of Urology Residency Applications on Selection for Interview During the COVID-19 Pandemic.
Urology
; 173: 34-40, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36513217
8.
A Procedural Checklist for Transurethral Resection of Bladder Tumors (TURBT) Enhances Operative Dictation and Assesses Surgeon Accuracy of Tumor Characteristic Predictions.
Bladder Cancer
; 9(4): 335-344, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38174124
9.
Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer
; 21(2): 258-264, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621462
10.
Low risk is low risk, regardless of race or ethnicity: Outcomes of prostate cancer active surveillance and factors associated with reclassification in a racially diverse cohort.
Urol Oncol
; 41(4): 204.e7-204.e15, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36740489
11.
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol Oncol
; 6(3): 313-320, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36803840
12.
Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy.
Clin Genitourin Cancer
; 20(6): e465-e472, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768315
13.
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(6): 558-567, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36155169
14.
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer
; 20(2): 165-175, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35078711
15.
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(5): e440-e452, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35778337
16.
Intravesical Bacillus Calmette-Guérin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non-muscle-invasive Bladder Cancer.
Clin Genitourin Cancer
; 19(6): e409-e416, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34116955
17.
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Eur Urol Oncol
; 4(3): 464-472, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33423945
18.
Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer.
Urol Oncol
; 38(9): 734.e19-734.e25, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32321689
19.
An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle-invasive bladder cancer.
Urol Oncol
; 38(2): 40.e17-40.e24, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31473090
20.
Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer.
Urol Oncol
; 38(1): 5.e9-5.e16, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31255541